The Global COVID-19 Rapid Antibody Test Kits Market was valued at USD 43.39 Billion in 2023 and is projected to maintain demand through 2032 with North America accounting for USD 11.3 Billion of the market. These critical diagnostic tools provide qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood within 10-30 minutes, serving as essential components in both clinical and point-of-care settings.
As global healthcare systems transition from pandemic to endemic management, rapid antibody testing continues playing a vital role in seroprevalence studies, vaccine response monitoring, and public health surveillance. This analysis examines the Top 10 Companies in the COVID-19 Rapid Antibody Test Kits Market—diagnostic leaders combining scientific innovation with large-scale manufacturing capabilities to support worldwide testing needs.
Download FREE Sample Report:
COVID-19 Rapid Antibody Test Kits Market – View in Detailed Research Report
🔟 1. Roche Diagnostics
Headquarters: Basel, Switzerland
Key Offering: Elecsys Anti-SARS-CoV-2, SARS-CoV-2 Rapid Antibody Test
Roche’s automated immunoassay solutions dominate hospital laboratory settings with FDA-EUA approved tests achieving 99.8% specificity. Their modular analyzers process up to 300 tests/hour, serving over 30,000 laboratories globally.
Diagnostic Advantages:
- High-throughput platforms (Cobas, Elecsys) with 29 global production sites
- 95% agreement with PCR confirmatory testing
- Quantitative antibody level measurement capability
9️⃣ 2. Abbott Laboratories
Headquarters: Chicago, Illinois, USA
Key Offering: AdviseDx SARS-CoV-2 IgG II, BinaxNOW
Abbott’s multi-platform approach spans centralized labs and decentralized testing, having distributed over 1 billion COVID tests globally including their 15-minute BinaxNOW rapid antigen test.
Diagnostic Advantages:
- CLIA-waived point-of-care solutions
- Neutralizing antibody detection technology
- Global logistics network serving 100+ countries
Download FREE Sample Report:
COVID-19 Rapid Antibody Test Kits Market – View in Detailed Research Report
8️⃣ 3. SD Biosensor
Headquarters: Suwon, South Korea
Key Offering: STANDARD Q COVID-19 IgM/IgG Rapid Test
This Korean manufacturer achieved WHO Emergency Use Listing for its STANDARD Q test, supplying over 200 million test kits globally with 97.6% sensitivity for IgM detection.
Diagnostic Advantages:
- Partnerships with 78 national health ministries
- Integrated manufacturing from R&D to mass production
- Stable at room temperature (2-30°C)
7️⃣ 4. Siemens Healthineers
Headquarters: Erlangen, Germany
Key Offering: Atellica IM SARS-CoV-2 IgG, CLINITEST Rapid COVID-19
Siemens’ automated analyzers deliver lab-grade results with Atellica systems processing 96 samples/hour, while their rapid tests detect antibody levels as low as 0.8 U/mL for precise immune response monitoring.
Diagnostic Advantages:
- Fully automated laboratory workflows
- EUA for semi-quantitative results
- Interoperability with hospital LIS systems
6️⃣ 5. Thermo Fisher Scientific
Headquarters: Waltham, Massachusetts, USA
Key Offering: OmniPATH COVID-19 Total Antibody ELISA Test
Thermo Fisher’s ELISA-based antibody tests serve large-scale serological studies with 100% specificity and 96.7% sensitivity, validated across 1,300+ PCR-confirmed samples.
Diagnostic Advantages:
- Scalable ELISA platform for population studies
- Automated processing on Phadia systems
- CE-IVD marked for professional use
5️⃣ 6. Bio-Rad Laboratories
Headquarters: Hercules, California, USA
Key Offering: Platelia SARS-CoV-2 Total Ab assay
Bio-Rad’s quantitative antibody test measures IgG against nucleocapsid and spike proteins, supporting longitudinal immunity studies with precision down to 444 BAU/mL.
Diagnostic Advantages:
- Automated processing on BioPlex systems
- Standardized WHO unit reporting
- 6-month shelf life at 2-8°C
Get Full Report Here:
COVID-19 Rapid Antibody Test Kits Market – View in Detailed Research Report
4️⃣ 7. QuidelOrtho Corporation
Headquarters: San Diego, California, USA
Key Offering: Sofia SARS Total Antibody FIA
QuidelOrtho’s fluorescent immunoassay runs on the Sofia system, delivering quantitative antibody results in 30 minutes with 98.8% specificity across 400+ negative specimens.
Diagnostic Advantages:
- Simultaneous IgG/IgM detection
- CLIA moderate complexity classification
- Integrated LIS connectivity
3️⃣ 8. DiaSorin
Headquarters: Saluggia, Italy
Key Offering: LIAISON SARS-CoV-2 S1/S2 IgG
This Italian innovator’s chemiluminescent assay detects IgG against SARS-CoV-2 spike protein with 98.5% specificity, widely adopted in European healthcare systems.
Diagnostic Advantages:
- Fully automated LIAISON XL platform
- 17-month shelf life
- Minimal cross-reactivity with other coronaviruses
2️⃣ 9. BioMérieux
Headquarters: Marcy-l’Étoile, France
Key Offering: VIDAS SARS-CoV-2 IgG/IgM
BioMérieux’s automated fluorescence immunoassay provides qualitative IgG/IgM results in 50 minutes, with CE-IVD certification across Europe and other global markets.
Diagnostic Advantages:
- Integration with VIDAS 3 instrumentation
- 12-month shelf life at 2-8°C
- Validated for plasma, serum, and dried blood spots
1️⃣ 10. Ortho Clinical Diagnostics
Headquarters: Raritan, New Jersey, USA
Key Offering: VITROS Anti-SARS-CoV-2 Total
Ortho’s high-throughput chemiluminescent assay processes 170 tests/hour on VITROS systems, achieving 99.6% specificity in multicentre evaluations.
Diagnostic Advantages:
- FDA Emergency Use Authorization
- ROCHE/ABBOTT assay comparability data
- Standardized reporting in BAU/mL
Download FREE Sample Report:
COVID-19 Rapid Antibody Test Kits Market – View in Detailed Research Report
🩺 Market Outlook: Evolving Applications of Antibody Testing
The COVID-19 rapid antibody test market continues expanding beyond acute diagnosis into new clinical and public health applications:
- Vaccine development – Monitoring immune response in clinical trials
- Donor screening – Identifying convalescent plasma candidates
- Population immunity mapping – Seroprevalence studies for public health planning
- Hybrid immunity assessment – Evaluating vaccine-plus-infection protection
Key Technological Advancements
- Multiplex platforms detecting COVID-19 variants + influenza
- Smartphone-based result documentation and reporting
- Environmental resilience for tropical climates
- Neutralization surrogate assays
Get Full Report Here:
COVID-19 Rapid Antibody Test Kits Market – View in Detailed Research Report
These market leaders continue advancing diagnostic technologies to meet the evolving needs of global healthcare systems, demonstrating how rapid antibody testing remains a cornerstone of pandemic preparedness and respiratory disease management.